Here are the 10-K annual reports from Scientist Home FTR Hlth (SHFH) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-K covers the audited annual report, with the full financial statements, so if you follow SHFH and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SHFH filings page.
Scientist Home Future Health Limited reported its first full year of operations with 2025 revenue of $204,055, mainly from retail sales of health supplements and topical creams, plus physical check-up services. Despite this growth from 2024’s $120,775, the company posted a net loss of $231,725, reflecting high rental, professional and start-up operating expenses.
At December 31, 2025, cash was $68,888 against current liabilities of $214,458, resulting in net current liabilities of $22,212 and an accumulated deficit of $246,705. Both management and the auditor concluded these conditions raise substantial doubt about the company’s ability to continue as a going concern. The business relies heavily on related parties for product supply, office leases and funding, while the CEO controls about 84% of the 23,716,000 outstanding shares.
The stock is quoted on the OTC market under symbol SHFH and is likely to be treated as a penny stock, which may limit trading liquidity. Internal controls over financial reporting are described as ineffective due to lack of segregation of duties, absence of an independent board or audit committee, and missing formal control documentation.